Office at 4F-10, Al Khaimah Building II, 118-0 Al Barsha First, Dubai, United Arab Emirates. 9.00 am - 6.00 pm

Pharmaceutical Regulatory Affairs

The Role of the Regulatory Affairs

We specialize in managing regulatory approvals and creating and maintaining related documents. Lema already processes over 1,500 dossiers and Rx OTC switches. From creating a CTD dossier.

The 'Regulatory Activities' area includes all the work required to obtain and maintain a drug approval or registration. Dossiers are at the forefront of this process.

Lema Project Management LLC's Regulatory Affairs Manager compiles drug information on behalf of pharmaceutical companies and presents it in the format required by authorities.

For over 25 years, customers have relied on our expertise in creating and maintaining such dossiers. On behalf of the client, all information relating to clinical studies, medical safety and efficacy studies, drug quality, analytical testing, approved uses, pharmacovigilance, etc., is submitted to one (electronic) common technical document, also known as the eCTD dossier and Marketing approval.

Our Regulatory Affairs Managers advise pharmaceutical companies on how to bring medicines to market without delay and how to keep them on the market throughout their lifecycle.

We assess existing documents/documents, point out strategic and regulatory options, and support scientific advice with responsible authorities. We also manage certification projects.

  • National Accreditation Procedures
  • Mutual Recognition Procedures (MRP)
  • Decentralized Procedures (DCP)
  • Centralized Procedures (CP)

Products are licensed for marketing. Our regulatory affairs managers update existing documentation to reflect current regulatory requirements and accommodate changes as needed. Depending on the situation and needs, you may also have direct drug responsibility as an Information Officer, Qualified Pharmacovigilance Person (QPPV), Qualified Person (QP) or Marketing Authorization Holder (MAH).

Get in Touch